This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sanofi, Centre National De La Recherche Scientifique, Université Paul Sabatier (Toulouse III). Active years: 2016-2026.
Company Filing History:
2 out of 1,540 
1 out of 5,383 
1 out of 160 
Years Active: 2016-2026
Title: Fethi Bensaid: Innovator in Antibody-Drug Conjugate Formulations
Introduction
Fethi Bensaid is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work has the potential to impact cancer treatment and drug delivery systems.
Latest Patents
Bensaid's latest patents include the "CEACAM5 Antibody-Drug Conjugate Formulation" and "Polymeric Conjugates of Active Principles, Their Process of Preparation and Their Polymeric Intermediates." The latter invention relates to novel conjugates of active principles grafted to a polymer, as well as the nanoparticles comprising them and their preparation processes. These innovations aim to enhance the efficacy and targeting of therapeutic agents.
Career Highlights
Throughout his career, Bensaid has worked with prominent organizations such as Sanofi and Université Paul Sabatier (Toulouse III). His experience in these institutions has allowed him to collaborate on various research projects and contribute to advancements in drug formulation technologies.
Collaborations
Bensaid has collaborated with notable colleagues, including Eric Didier and Didier Bourissou. Their joint efforts have furthered the research and development of innovative pharmaceutical solutions.
Conclusion
Fethi Bensaid's contributions to the field of antibody-drug conjugates and polymeric formulations highlight his role as an influential inventor. His work continues to pave the way for advancements in targeted therapies and drug delivery systems.